Literature DB >> 25697060

Frailty in NHANES: Comparing the frailty index and phenotype.

Joanna Blodgett1, Olga Theou2, Susan Kirkland3, Pantelis Andreou1, Kenneth Rockwood4.   

Abstract

The two most commonly employed frailty measures are the frailty phenotype and the frailty index. We compared them to examine whether they demonstrated common characteristics of frailty scales, and to examine their association with adverse health measures including disability, self-reported health, and healthcare utilization. The study examined adults aged 50+ (n=4096) from a sequential, cross-sectional sample (2003-2004; 2005-2006), National Health and Nutrition Examination Survey. The frailty phenotype was modified from a previously adapted version and a 46-item frailty index was created following a standard protocol. Both measures demonstrated a right-skewed distribution, higher levels of frailty in women, exponential increase with age and associations with high healthcare utilization and poor self-reported health. More people classified as frail by the modified phenotype had ADL disability (97.8%) compared with the frailty index (56.6%) and similarly for IADL disability (95% vs. 85.6%). The prevalence of frailty was 3.6% using the modified frailty phenotype and 34% using the frailty index. Frailty index scores in those who were classified as robust by the modified phenotype were still significantly associated with poor self-reported health and high healthcare utilization. The frailty index and the modified frailty phenotype each confirmed previously established characteristics of frailty scales. The agreement between frailty and disability was high with each measure, suggesting that frailty is not simply a pre-disability stage. Overall, the frailty index classified more people as frail, and suggested that it may have the ability to discriminate better at the lower to middle end of the frailty continuum.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Disability; Frailty; Index; Phenotype

Mesh:

Year:  2015        PMID: 25697060     DOI: 10.1016/j.archger.2015.01.016

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  95 in total

1.  Predicting Mortality and Adverse Outcomes: Comparing the Frailty Index to General Prognostic Indices.

Authors:  Sandra M Shi; Ellen P McCarthy; Susan L Mitchell; Dae Hyun Kim
Journal:  J Gen Intern Med       Date:  2020-02-18       Impact factor: 5.128

2.  Dietary Inflammatory Index, Pre-Frailty and Frailty among Older US Adults: Evidence from the National Health and Nutrition Examination Survey, 2007-2014.

Authors:  N V Resciniti; M C Lohman; M D Wirth; N Shivappa; J R Hebert
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  Editorial: Frailty, Comorbidity, and COPD.

Authors:  E Charbek; J R Espiritu; R Nayak; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study.

Authors:  Dae Hyun Kim; Robert J Glynn; Jerry Avorn; Lewis A Lipsitz; Kenneth Rockwood; Ajinkya Pawar; Sebastian Schneeweiss
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-07-12       Impact factor: 6.053

5.  Near Vision Impairment and Frailty: Evidence of an Association.

Authors:  Varshini Varadaraj; Moon Jeong Lee; Jing Tian; Pradeep Y Ramulu; Karen Bandeen-Roche; Bonnielin K Swenor
Journal:  Am J Ophthalmol       Date:  2019-08-26       Impact factor: 5.258

6.  Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.

Authors:  Nicholas M Pajewski; Jeff D Williamson; William B Applegate; Dan R Berlowitz; Linda P Bolin; Glenn M Chertow; Marie A Krousel-Wood; Nieves Lopez-Barrera; James R Powell; Christianne L Roumie; Carolyn Still; Kaycee M Sink; Rocky Tang; Clinton B Wright; Mark A Supiano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-11       Impact factor: 6.053

7.  Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.

Authors:  Alejandra Gullón; Francesc Formiga; Jesús Díez-Manglano; José María Mostaza; José María Cepeda; Antonio Pose; Jesús Castiella; Carmen Suárez-Fernández
Journal:  Intern Emerg Med       Date:  2018-09-06       Impact factor: 3.397

8.  Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype.

Authors:  Jodi B Segal; Hsien-Yen Chang; Yu Du; Jeremy D Walston; Michelle C Carlson; Ravi Varadhan
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

9.  Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.

Authors:  Parag Goyal; Joanna Bryan; Jerard Kneifati-Hayek; Madeline R Sterling; Samprit Banerjee; Mathew S Maurer; Mark S Lachs; Monika M Safford
Journal:  J Am Geriatr Soc       Date:  2018-11-29       Impact factor: 5.562

10.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.